1.1.1-Trifluoroethane is a colorless, highly flammable gas. It is heavier than air and vapors may travel from a leaking container to a source of ignition causing a flame to flashback to the container. Contact with the unconfined liquid can cause frostbite. Under prolonged exposure to fire or heat the containers may rupture violently and rocket.
颜色/状态:
Colorless gas
沸点:
-47.5 °C
熔点:
-111.3 °C
溶解度:
In water, 548 mg/L at 25 °C (est)
蒸汽密度:
3.1 (Air = 1)
蒸汽压力:
1262 kPa at 298.165 deg K (9465 mm Hg at 25 °C)
大气OH速率常数:
1.70e-15 cm3/molecule*sec
分解:
When heated to decomposition it emits toxic vapors of /flouride/.
IDENTIFICATION AND USE: 1,1,1-Trifluoroethane (HFC-143a) is a colorless gas. It is used to make other chemicals and may be used as a refrigerant. HUMAN EXPOSURE AND TOXICITY: There was no significant increase in chromosome aberrations when human lymphocytes were exposed to the substance in vitro. ANIMAL STUDIES: HFC-143a has a very low acute inhalation toxicity potential as shown by a 4-hr LC50 of > 540,000 ppm in rats. HFC-143A has a low potential to induce cardiac sensitization in experimental screening studies in dogs; only the highest concentration tested--300,000 ppm--elicited a cardiac sensitization response. In one study, a 3% solution of 1,1,1-trifluoroethane in corn oil was given to rats by gavage in doses of 300 mg/kg body weight, 5 days/week for 52 weeks. The animals were killed on week 125. Males had significantly lower body weights from week 28 to week 88. No other exposure-related effects were observed: there was no significant increase of cancer incidence in any organ. One study reports that 1,1,1-trifluoroethane had mutagenic effects on two of four strains of Salmonella typhimurium when tested in vitro, both with and without metabolic activation. Another study reports that mutagenic effects could not be observed when the substance was tested, either with or without addition of metabolizing systems, on a total of six strains of Salmonella typhimurium and two strains of E coli. In cell transformation tests on mammalian cells in vitro, 1,1,1- trifluoroethane had no observed mutagenic effect. Further, there was no significant increase of micronuclei in bone marrow cells of mice that had been exposed to 40,000, 10,000 or 2000 ppm 1,1,1-trifluoroethane 6 hours/day for two days. No maternal or developmental toxicity was noted after exposure to HFC-143a even at 40,000 ppm in rats or rabbits. No evidence of teratogenicity was noted in rats or rabbits.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
副作用
神经毒素 - 急性溶剂综合征
Neurotoxin - Acute solvent syndrome
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
毒理性
毒性数据
大鼠LC50 > 540,000 mg/m³/4小时
LC50 (rat) > 540,000 ppm/4h
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases
Immediate first aid: Ensure that adequate decontamination has been carried out. If patient is not breathing, start artificial respiration, preferably with a demand-valve resuscitator, bag-valve-mask device, or pocket mask, as trained. Perform CPR if necessary. Immediately flush contaminated eyes with gently flowing water. Do not induce vomiting. If vomiting occurs, lean patient forward or place on left side (head-down position, if possible) to maintain an open airway and prevent aspiration. Keep patient quiet and maintain normal body temperature. Obtain medical attention. /Chlorinated fluorocarbons (CFCs) and related compounds/
Basic treatment: Establish a patent airway (oropharyngeal or nasopharyngeal airway, if needed). Suction if necessary. Watch for signs of respiratory insufficiency and assist ventilations as needed. Administer oxygen by nonrebreather mask at 10 to 15 L/min. Minimize physical activity and provide a quiet atmosphere. Monitor for pulmonary edema and treat if necessary ... . Anticipate seizures and treat if necessary ... . For eye contamination, flush eyes immediately with water. Irrigate each eye continuously with 0.9% saline (NS) during transport ... . Do not use emetics. Rinse mouth and administer 5 mL/kg up to 200 mL of water for dilution if the patient can swallow, has a strong gag reflex, and does not drool. Administer activated charcoal ... . Treat frostbite with rapid rewarming techniques ... . /Chlorinated fluorocarbons (CFCs) and related compounds/
The aim of this study was to determine the toxicokinetics and some effects of 1,1,1-trifluoroethane (HFC-143a) in humans. Nine male volunteers were experimentally exposed to 500 ppm HFC-143a for 2 hr during light physical exercise (50W) in an exposure chamber. Blood, urine and exhaled air were sampled before, during and up to 19 hr after exposure and analyzed for HFC-143a by gas chromatography. These data were described by a physiologically based toxicokinetic (PBTK) model. The electrocardiograms of the volunteers were monitored during exposure. Before, during and after exposure the volunteers rated symptoms related to irritation and CNS-symptoms on a visual analogue scale. Inflammatory markers (C-reactive protein, serum amyloid A protein, D-dimer, fibrinogen) and uric acid were analyzed in plasma collected before and 21 hr after exposure. The exposures were performed after informed consent and ethical approval. The plasma concentration of HFC-143a increased promptly at start of exposure, and decreased in the same manner post-exposure. A stable level of 4.8+/-2.0 microM (mean+/-S.D.) was reached within 30 min of exposure. The HFC-143a concentration in plasma and exhaled air decreased fast and in parallel when exposure was stopped. The urinary excretion of HFC-143a after exposure was 0.0007% of the inhaled amount. The half-time in urine, calculated from pooled data, was 53 min. The experimental and simulated time courses in blood and exhaled air were in agreement. The simulated relative uptake during the exposure was 1.6+/-0.3%. The fibrinogen level in plasma had increased by 11% 1 day post-exposure. No statistically significant increase was seen for the other inflammatory markers or for uric acid. No effects of exposure were seen either in the electrocardiographic monitorings or as symptom ratings on the visual analogue scale.
Various hydrofluorocarbons (HFCs) have replaced the ozone-depleting chlorofluorocarbons and hydrochlorofluorocarbons during the last decades. The objective of this study was to examine the usefulness of blood and breath for exposure biomonitoring of HFCs. We compared data on blood and exhaled air from a series of experiments where healthy volunteers were exposed to vapors of four commonly used HFCs; 1,1-difluoroethane, 1,1,1-trifluoroethane, 1,1,1,2-tetrafluoroethane, and 1,1,1,3,3-pentafluoropropane. All four HFCs had similar toxicokinetic profiles in blood with a rapid initial increase and an apparent steady-state reached within a few minutes. For all HFCs, the inhalation uptake during exposure was low (less than 6%), most of which was exhaled post-exposure. No metabolism could be detected and only minor amounts were excreted unchanged in urine. The observed time courses in blood and breath were well described by physiologically-based pharmacokinetic (PBPK) modeling. Simulations of 8-hr exposures show that the HFC levels in both blood and breath drop rapidly during the first minutes post-exposure, whereafter the decline is considerably slower and mainly reflects washout from fat tissues. We conclude that blood and exhaled air can be used for biological exposure monitoring. Samples should not be taken immediately at the end of shift but rather 20-30 min later.
Isomerization and Decomposition of Indole. Experimental Results and Kinetic Modeling
摘要:
The thermal reactions of indole were studied behind reflected shocks in a pressurized driver single-pulse shock tube over the temperature range 1050-1650 K and densities of similar to 3 x 10(-5) mol/cm(3). Similar to pyrrole, the main thermal reactions of indole are isomerizations. Three isomerization products are obtained under shock heating as a result of the pyrrole ring opening. These isomers are benzyl cyanide, o- and m-tolunitriles. Studies with toluene as a free-radical scavenger shows no effect on the production rates of these isomers. The decomposition products that were found in the postshock samples in decreasing order of abundance were C2H2, HCN, HC=CCN, C4H2, C6H5CN, CH3CN, and C6H6. Small quantities of C6H5-CH3, CH4, C5H5-CN, CH2CHCN, C5H6, C6H5-C=CH and traces of C2H4, CH2=C=CH2, CH3-C=CH, C2H4, C6H4, and C5H5-C=CH were also found in the postshock mixtures. The total disappearance of indole in terms of a first-order rate constant is given by k(total) = 10(15.78) exp(-83.6 x 10(3)/RT)s(-1) where R is expressed in units of cal/(K mol). At high temperatures the extent of fragmentation increases, and around 1300 K the fragmentation begins to exceeds that of the isomerizations. It is suggested that indole --> benzyl cyanide isomerization starts with cleavage of the C(9)-N(1) bond followed by two 1,2 H-atom migrations. The mechanism of indole --> tolunitrile isomerization involves a series of unimolecular steps which are preceded by the very fast indole <----> indolenine tautomerism. The thermal decomposition of indole is initiated by H-atom ejection from the reactant. A reaction scheme containing 48 species 109 elementary reactions accounts for the observed product distribution. First-order Arrhenius rate parameters for the formation of the various reaction products are given, a reaction scheme is suggested, and results of computer simulation and sensitivity analysis are shown. Differences and similarities in the reactions of pyrrole and indole are discussed.
[EN] CATALYTIC FLUORINATION PROCESS OF MAKING HYDROHALOALKANE<br/>[FR] PROCÉDÉ DE PRODUCTION D'UN HYDROHALOALCANE PAR FLUORATION CATALYTIQUE
申请人:NAPPA MARIO JOSEPH
公开号:WO2013071024A1
公开(公告)日:2013-05-16
The present disclosure provides a fluorination process which involves reacting a hydrohaloalkene of the formula RfCCl=CH2 with HF in a reaction zone in the presence of a fluorination catalyst selected from the group consisting of TaF5 and TiF4 to produce a product mixture containing a hydrohaloalkane of the formula RfCFClCH3, wherein Rf is a perfluorinated alkyl group.
A manufacturing process for making hydrofluorocarbons (HFCs), by reacting a hydrochlorocarbon and HF in a liquid phase catalytic reactor using a large mole ratio of HF to hydrochlorocarbon to minimize formation of high boiling by-products and improve HF consumption and hydrofluorocarbon yields.
The present invention relates to the pyrolysis of hydrochlorofluorocarbons to form fluoromonomers such as tetrafluoroethylene, the pyrolysis being carried out in a reaction zone lined with nickel and mechanically supported by a jacket of other corrosion resistant metal, the nickel lining providing an improved yield of valuable reaction products.
In the production of fluorine-containing olefins using a chlorine-containing alkane or a chlorine-containing alkene as a starting material, a process for producing a plurality of useful fluorine-containing olefins with high selectivity using the same raw material, the same equipment, and the same conditions is provided. The present invention provides a process for producing fluorine-containing olefins, the process comprising reacting a chlorine-containing compound represented by a specific formula and anhydrous hydrogen fluoride in the presence of oxidative gas and a fluorination catalyst, wherein the fluorination catalyst is a catalyst in which at least one metal element M selected from the group consisting of Group VIII and Group IX is present together with chromium. This production process can simultaneously produce two or more fluorine-containing olefin compounds, including HFO-1234yf and HFO-1234ze, with high selectivity.
[EN] PROCESS FOR THE CO-PRODUCTION OF OF 2,3,3,3-TETRAFLUOROPROPENE AND 1,3,3,3-TETRAFLUOROPROPENE<br/>[FR] PROCÉDÉ DE CO-PRODUCTION DE 2,3,3,3-TÉTRAFLUOROPROPÈNE ET DE 1,3,3,3-TÉTRAFLUOROPROPÈNE
申请人:MEXICHEM FLUOR SA DE CV
公开号:WO2017013407A1
公开(公告)日:2017-01-26
The present invention provides a method of producing 2,3,3,3-tetrafluoropropene (HFO- 1234yf), wherein the method comprises two or more reaction steps, at least one of said reaction steps comprising the production of 1,3,3,3-tetrafluoropropene (HFO-1234ze) and/or one or more HFO-1234ze precursors from one or more HFO-1234yf precursors, wherein at least a portion of the HFO-1234ze is recovered.